
Cochlear obtains FDA approval for first remote programming option for cochlear implants
CENTENNIAL -- Cochlear Limited (ASX: COH), a leader in implantable hearing solutions, has received U.S. Food and Drug Administration (FDA) approval for the first remote feature to allow... Read More
Tuesday November 28, 2017